文献速递细菌感染、耐药与抗菌药物医院感染防控

15家退伍军人医院实施氟喹诺酮与头孢菌素限制的可行性混合方法研究

The feasibility of implementing antibiotic restrictions for fluoroquinolones and cephalosporins: a mixed-methods study across 15 Veterans Health Administration hospitals.
PubMed 文献 · J Antimicrob Chemother · 2021-01-01

该混合方法研究于2018年9月至2019年5月在15家地理分散的退伍军人急性照护医院开展电子调查和半结构化访谈,调查抗生素管理策略并访谈30名ASP骨干及5家子集医院的19名额外利益相关者。结果显示莫西沙星是限制最多的药物(12家,80%),无医院限制头孢曲松;访谈对限制第三代/第四代头孢菌素和氟喹诺酮的可行性存在分歧。

要点

  • 莫西沙星在12家(80%)医院被限制,15家医院均未限制头孢曲松。
  • 对限制三代/四代头孢菌素和氟喹诺酮的可行性存在不同意见。
  • 部分受访者认为限制可不增加临床负担且不干扰及时用药,另一些担忧预先审批的频繁使用和执行困难。

核心结论

  • 15家医院对实施三代/四代头孢菌素和氟喹诺酮限制的可行性意见不一。
  • 尽管感知障碍常较高,但许多医院有效使用了限制且报告障碍较少。

研究设计与样本

  • 混合方法研究,目的性抽样15家地理分散的退伍军人急性照护医院。
  • 2018年9月至2019年5月开展电子调查和半结构化访谈,访谈30名ASP骨干及5家子集医院的19名额外利益相关者,转录采用主题内容分析。

主要发现

  • 莫西沙星是限制最多的药物,在12家(80%)医院被限制。
  • 15家医院均未限制头孢曲松。
  • 访谈对限制三代/四代头孢菌素和氟喹诺酮的可行性存在不同观点。
  • 部分参与者认为限制可不增加临床负担且不干扰及时抗生素给药,另一些担忧频繁使用、执行困难及引导临床医生使用非限制抗生素的潜在非预期后果。
  • 多种管理策略被认为可有效减少这些药物的使用。

临床怎么用

  • 临床可参考莫西沙星等氟喹诺酮的限制经验,但头孢曲松未被限制。
  • 实施限制时需权衡频繁使用与执行负担,关注预先审批的潜在非预期后果。
  • 多种管理策略被认为有效减少三代/四代头孢菌素和氟喹诺酮使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The optimal method for implementing hospital-level restrictions for antibiotics that carry a high risk of Clostridioides difficile infection has not been identified. We aimed to explore barriers and facilitators to implementing restrictions for fluoroquinolones and third/fourth-generation cephalosporins. METHODS: This mixed-methods study across a purposeful sample of 15 acute-care, geographically dispersed Veterans Health Administration hospitals included electronic surveys and semi-structured interviews (September 2018 to May 2019). Surveys on stewardship strategies were administered at each hospital and summarized with descriptive statistics. Interviews were performed with 30 antibiotic stewardship programme (ASP) champions across all 15 sites and 19 additional stakeholders at a subset of 5 sites; transcripts were analysed using thematic content analysis. RESULTS: The most restricted agent was moxifloxacin, which was restricted at 12 (80%) sites. None of the 15 hospitals restricted ceftriaxone. Interviews identified differing opinions on the feasibility of restricting third/fourth-generation cephalosporins and fluoroquinolones. Some participants felt that restrictions could be implemented in a way that was not burdensome to clinicians and did not interfere with timely antibiotic administration. Others expressed concerns about restricting these agents, particularly through prior approval, given their frequent use, the difficulty of enforcing restrictions and potential unintended consequences of steering clinicians towards non-restricted antibiotics. A variety of stewardship strategies were perceived to be effective at reducing the use of these agents. CONCLUSIONS: Across 15 hospitals, there were differing opinions on the feasibility of implementing antibiotic restrictions for third/fourth-generation cephalosporins and fluoroquinolones. While the perceived barrier to implementing restrictions was frequently high, many hospitals were effectively using restrictions and reported few barriers to their use.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Livorsi DJ, Suda KJ, Cunningham Goedken C, et al. The feasibility of implementing antibiotic restrictions for fluoroquinolones and cephalosporins: a mixed-methods study across 15 Veterans Health Administration hospitals. J Antimicrob Chemother. 2021. PMID: 34015115. doi:10.1093/jac/dkab138

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。